Sklamberg Quoted in Modern Healthcare on FDA Policy Priorities Under Califf

November 22, 2021

Life Sciences & Healthcare Regulatory partner Howard Sklamberg was quoted in a recent article from Modern Healthcare, “Five FDA Policy Themes to Watch for Under New Leadership.” The article discusses potential policy priorities for Robert Califf, Biden’s choice for head of the US Food and Drug Administration. Sklamberg, who worked as deputy commissioner at the FDA during Califf’s first tenure, summarizes the priorities expected under the agency’s new leadership.

» Read the full article (subscription required).


Email Disclaimer